283 related articles for article (PubMed ID: 24107396)
1. Screening of gastric cancer: who, when, and how.
Lin JT
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):135-8. PubMed ID: 24107396
[TBL] [Abstract][Full Text] [Related]
2. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies.
de Vries AC; Kuipers EJ
Helicobacter; 2007 Nov; 12 Suppl 2():22-31. PubMed ID: 17991173
[TBL] [Abstract][Full Text] [Related]
4. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.
Con SA; Con-Wong R; Con-Chin GR; Con-Chin VG; Takeuchi H; Valerín AL; Echandi G; Mena F; Brenes F; Yasuda N; Araki K; Sugiura T
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2631-6. PubMed ID: 18086767
[TBL] [Abstract][Full Text] [Related]
5. Eradication of gastric cancer is now both possible and practical.
Shiotani A; Cen P; Graham DY
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):492-501. PubMed ID: 23876852
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
7. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
[TBL] [Abstract][Full Text] [Related]
8. The non-invasive diagnosis of precancerous changes of stomach mucosa.
Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Polyakova MB; Mernova VP
Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316
[TBL] [Abstract][Full Text] [Related]
9. Early diagnosis of early gastric cancer.
Tan YK; Fielding JW
Eur J Gastroenterol Hepatol; 2006 Aug; 18(8):821-9. PubMed ID: 16825897
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
[TBL] [Abstract][Full Text] [Related]
11. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
12. Risk factors in gastric cancer.
Compare D; Rocco A; Nardone G
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):302-8. PubMed ID: 20496539
[TBL] [Abstract][Full Text] [Related]
13. Using serum pepsinogens wisely in a clinical practice.
Miki K; Urita Y
J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
15. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
17. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice.
Quach DT; Hiyama T; Gotoda T
World J Gastroenterol; 2019 Jul; 25(27):3546-3562. PubMed ID: 31367156
[TBL] [Abstract][Full Text] [Related]
18. Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence?
Mohamadkhani A; Darvish Moghaddam S; Salmanroghani H; Allafsghari A; Yazdanbod A; Mirzaei M; Haj-sheykholeslami A; Bashiri J; Sadjadi A; Massarrat S
Arch Iran Med; 2013 Apr; 16(4):208-12. PubMed ID: 23496362
[TBL] [Abstract][Full Text] [Related]
19. Asia-Pacific consensus guidelines on gastric cancer prevention.
Fock KM; Talley N; Moayyedi P; Hunt R; Azuma T; Sugano K; Xiao SD; Lam SK; Goh KL; Chiba T; Uemura N; Kim JG; Kim N; Ang TL; Mahachai V; Mitchell H; Rani AA; Liou JM; Vilaichone RK; Sollano J;
J Gastroenterol Hepatol; 2008 Mar; 23(3):351-65. PubMed ID: 18318820
[TBL] [Abstract][Full Text] [Related]
20. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.
Boda T; Ito M; Yoshihara M; Kitamura Y; Matsuo T; Oka S; Tanaka S; Chayama K
Helicobacter; 2014 Feb; 19(1):1-8. PubMed ID: 24215601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
